Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pericytes | 11 | 2022 | 81 | 6.770 |
Why?
|
| Capillaries | 10 | 2022 | 105 | 5.350 |
Why?
|
| Cerebrovascular Circulation | 10 | 2021 | 296 | 3.130 |
Why?
|
| Brain | 17 | 2022 | 2176 | 3.000 |
Why?
|
| Cerebral Infarction | 6 | 2018 | 103 | 2.950 |
Why?
|
| Cerebral Cortex | 10 | 2017 | 415 | 2.200 |
Why?
|
| Arterioles | 11 | 2022 | 40 | 2.180 |
Why?
|
| Neocortex | 4 | 2022 | 17 | 1.730 |
Why?
|
| Blood-Brain Barrier | 5 | 2020 | 99 | 1.400 |
Why?
|
| Mice | 32 | 2022 | 8474 | 1.320 |
Why?
|
| Endothelial Cells | 4 | 2021 | 384 | 1.300 |
Why?
|
| Animals | 47 | 2022 | 20880 | 1.290 |
Why?
|
| Hemodynamics | 5 | 2022 | 705 | 1.270 |
Why?
|
| Neurovascular Coupling | 2 | 2019 | 9 | 1.210 |
Why?
|
| Microvessels | 3 | 2021 | 43 | 1.200 |
Why?
|
| Neuroglia | 5 | 2019 | 136 | 0.970 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2021 | 236 | 0.920 |
Why?
|
| Optogenetics | 1 | 2022 | 20 | 0.850 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 1033 | 0.830 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2550 | 0.830 |
Why?
|
| Cognition Disorders | 2 | 2017 | 342 | 0.800 |
Why?
|
| Neuroimaging | 3 | 2021 | 122 | 0.780 |
Why?
|
| Neurons | 9 | 2022 | 881 | 0.740 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 20 | 0.710 |
Why?
|
| NF-E2-Related Factor 2 | 7 | 2007 | 110 | 0.710 |
Why?
|
| Endothelium | 1 | 2020 | 98 | 0.700 |
Why?
|
| Microscopy, Confocal | 8 | 2019 | 337 | 0.700 |
Why?
|
| Microcirculation | 2 | 2015 | 77 | 0.640 |
Why?
|
| Venules | 1 | 2017 | 8 | 0.620 |
Why?
|
| Brain Ischemia | 4 | 2017 | 665 | 0.620 |
Why?
|
| Moyamoya Disease | 1 | 2017 | 7 | 0.610 |
Why?
|
| Oxidative Stress | 7 | 2007 | 718 | 0.570 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2017 | 59 | 0.560 |
Why?
|
| Astrocytes | 5 | 2009 | 270 | 0.550 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 198 | 0.550 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 144 | 0.550 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 160 | 0.540 |
Why?
|
| Dementia | 1 | 2017 | 158 | 0.530 |
Why?
|
| Blood Vessels | 2 | 2013 | 102 | 0.530 |
Why?
|
| Antioxidants | 5 | 2007 | 304 | 0.520 |
Why?
|
| Photons | 3 | 2012 | 32 | 0.520 |
Why?
|
| Regional Blood Flow | 2 | 2021 | 168 | 0.520 |
Why?
|
| Vasodilation | 3 | 2017 | 85 | 0.500 |
Why?
|
| Skull | 2 | 2012 | 63 | 0.500 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.500 |
Why?
|
| Molecular Imaging | 1 | 2015 | 45 | 0.500 |
Why?
|
| Rats | 15 | 2017 | 5300 | 0.480 |
Why?
|
| Animals, Newborn | 4 | 2021 | 396 | 0.470 |
Why?
|
| Hemostatic Techniques | 1 | 2013 | 23 | 0.460 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 364 | 0.460 |
Why?
|
| Light | 1 | 2013 | 152 | 0.430 |
Why?
|
| Brain Infarction | 1 | 2012 | 54 | 0.420 |
Why?
|
| Craniotomy | 1 | 2012 | 33 | 0.410 |
Why?
|
| Glutathione | 4 | 2006 | 343 | 0.410 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 105 | 0.400 |
Why?
|
| Microscopy | 1 | 2012 | 64 | 0.400 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 82 | 0.400 |
Why?
|
| Dementia, Vascular | 2 | 2021 | 22 | 0.370 |
Why?
|
| Neuroprotective Agents | 3 | 2012 | 317 | 0.360 |
Why?
|
| Brain Mapping | 1 | 2012 | 531 | 0.350 |
Why?
|
| Trans-Activators | 3 | 2005 | 237 | 0.330 |
Why?
|
| Actins | 2 | 2022 | 249 | 0.330 |
Why?
|
| Autism Spectrum Disorder | 2 | 2021 | 111 | 0.320 |
Why?
|
| Rodentia | 4 | 2018 | 27 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 2791 | 0.320 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 3 | 2019 | 27 | 0.310 |
Why?
|
| White Matter | 2 | 2021 | 174 | 0.310 |
Why?
|
| Somatosensory Cortex | 3 | 2012 | 22 | 0.300 |
Why?
|
| Meninges | 1 | 2007 | 7 | 0.290 |
Why?
|
| Cytoprotection | 1 | 2007 | 39 | 0.290 |
Why?
|
| Cystine | 1 | 2006 | 20 | 0.280 |
Why?
|
| Vibrissae | 3 | 2017 | 6 | 0.280 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 700 | 0.270 |
Why?
|
| Green Fluorescent Proteins | 3 | 2021 | 200 | 0.270 |
Why?
|
| Veins | 2 | 2022 | 68 | 0.260 |
Why?
|
| Dopamine | 2 | 2007 | 474 | 0.250 |
Why?
|
| Microglia | 1 | 2006 | 143 | 0.250 |
Why?
|
| Glutamic Acid | 3 | 2006 | 332 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 333 | 0.240 |
Why?
|
| Humans | 17 | 2021 | 68549 | 0.230 |
Why?
|
| Blood Flow Velocity | 3 | 2015 | 172 | 0.230 |
Why?
|
| Stroke | 3 | 2017 | 2162 | 0.230 |
Why?
|
| Rats, Wistar | 5 | 2006 | 371 | 0.210 |
Why?
|
| Opsins | 1 | 2022 | 19 | 0.210 |
Why?
|
| Brain Injuries | 1 | 2006 | 268 | 0.210 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 59 | 0.210 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1174 | 0.200 |
Why?
|
| Oxygen | 2 | 2017 | 386 | 0.200 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 13 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 2222 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 17 | 0.190 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2021 | 10 | 0.190 |
Why?
|
| Male | 11 | 2021 | 37283 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2021 | 107 | 0.190 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1174 | 0.190 |
Why?
|
| Ablation Techniques | 1 | 2021 | 33 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 164 | 0.180 |
Why?
|
| Hypercapnia | 1 | 2020 | 17 | 0.180 |
Why?
|
| Mitochondria | 1 | 2005 | 643 | 0.180 |
Why?
|
| Autistic Disorder | 1 | 2021 | 77 | 0.180 |
Why?
|
| Time Factors | 5 | 2021 | 4655 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 102 | 0.180 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2011 | 100 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2012 | 2083 | 0.170 |
Why?
|
| Alleles | 1 | 2020 | 386 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2007 | 2673 | 0.160 |
Why?
|
| Neural Pathways | 3 | 2017 | 323 | 0.160 |
Why?
|
| Hypoxia | 2 | 2009 | 169 | 0.160 |
Why?
|
| Gamma Rhythm | 1 | 2017 | 1 | 0.150 |
Why?
|
| Corpus Callosum | 1 | 2017 | 29 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2017 | 18 | 0.150 |
Why?
|
| Intracranial Thrombosis | 1 | 2017 | 14 | 0.140 |
Why?
|
| Prevalence | 2 | 2020 | 1609 | 0.140 |
Why?
|
| Physical Stimulation | 1 | 2017 | 67 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.140 |
Why?
|
| Protease Inhibitors | 1 | 2017 | 76 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 176 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 114 | 0.140 |
Why?
|
| Temporal Lobe | 1 | 2017 | 125 | 0.140 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 134 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 145 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2019 | 597 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1549 | 0.130 |
Why?
|
| Aphasia | 1 | 2017 | 119 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2012 | 92 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1860 | 0.130 |
Why?
|
| Calcium | 2 | 2012 | 929 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 565 | 0.120 |
Why?
|
| Synapses | 1 | 2017 | 222 | 0.120 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 32 | 0.120 |
Why?
|
| Ethanol | 1 | 2019 | 892 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2013 | 46 | 0.110 |
Why?
|
| Memantine | 1 | 2012 | 10 | 0.110 |
Why?
|
| Dizocilpine Maleate | 1 | 2012 | 43 | 0.110 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 35 | 0.110 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 203 | 0.100 |
Why?
|
| Reperfusion | 2 | 2009 | 78 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 213 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 58 | 0.090 |
Why?
|
| Interneurons | 1 | 2011 | 70 | 0.090 |
Why?
|
| China | 2 | 2021 | 138 | 0.090 |
Why?
|
| Erythropoiesis | 1 | 2009 | 24 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 710 | 0.090 |
Why?
|
| Radon | 1 | 2009 | 8 | 0.090 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 3 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 201 | 0.090 |
Why?
|
| Cerebral Veins | 1 | 2009 | 6 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 191 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2009 | 137 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 981 | 0.080 |
Why?
|
| Hydroquinones | 2 | 2005 | 15 | 0.080 |
Why?
|
| Adenoviridae | 2 | 2005 | 295 | 0.070 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2007 | 10 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2009 | 954 | 0.070 |
Why?
|
| Free Radicals | 1 | 2007 | 65 | 0.070 |
Why?
|
| Cognition | 2 | 2021 | 512 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 134 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2007 | 191 | 0.070 |
Why?
|
| Female | 4 | 2020 | 38021 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 23 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2006 | 40 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 216 | 0.070 |
Why?
|
| Succinate Dehydrogenase | 1 | 2005 | 13 | 0.060 |
Why?
|
| Nitro Compounds | 1 | 2005 | 11 | 0.060 |
Why?
|
| Propionates | 1 | 2005 | 21 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 71 | 0.060 |
Why?
|
| COS Cells | 1 | 2005 | 155 | 0.060 |
Why?
|
| Methamphetamine | 1 | 2006 | 132 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 302 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2006 | 1692 | 0.060 |
Why?
|
| Placenta | 1 | 2005 | 101 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 258 | 0.060 |
Why?
|
| Electron Transport Complex I | 1 | 2003 | 20 | 0.060 |
Why?
|
| Transfection | 1 | 2005 | 782 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 473 | 0.050 |
Why?
|
| Genotype | 1 | 2005 | 785 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2022 | 22 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 682 | 0.050 |
Why?
|
| Cell Line | 1 | 2006 | 1752 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 37 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2005 | 331 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2005 | 470 | 0.050 |
Why?
|
| Dendritic Spines | 1 | 2022 | 76 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2021 | 31 | 0.050 |
Why?
|
| Cocaine | 1 | 2006 | 555 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2006 | 504 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 689 | 0.050 |
Why?
|
| Water | 1 | 2022 | 228 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.050 |
Why?
|
| Perfusion | 1 | 2021 | 131 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 266 | 0.050 |
Why?
|
| Inflammation | 1 | 2006 | 1030 | 0.040 |
Why?
|
| Middle Cerebral Artery | 2 | 2010 | 57 | 0.040 |
Why?
|
| Child | 2 | 2021 | 6401 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2021 | 212 | 0.040 |
Why?
|
| Visual Cortex | 1 | 2019 | 67 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 514 | 0.040 |
Why?
|
| Parents | 1 | 2021 | 309 | 0.040 |
Why?
|
| Rest | 1 | 2017 | 78 | 0.040 |
Why?
|
| Speech Therapy | 1 | 2017 | 19 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 2689 | 0.040 |
Why?
|
| Cell Death | 2 | 2011 | 329 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 1425 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 211 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2077 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 274 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2265 | 0.030 |
Why?
|
| Aging | 1 | 2019 | 911 | 0.030 |
Why?
|
| Response Elements | 2 | 2003 | 29 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1293 | 0.030 |
Why?
|
| Analog-Digital Conversion | 1 | 2011 | 2 | 0.020 |
Why?
|
| Alcoholism | 1 | 2019 | 1109 | 0.020 |
Why?
|
| Cerebrum | 1 | 2010 | 20 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 47 | 0.020 |
Why?
|
| Bone Cements | 1 | 2010 | 39 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 114 | 0.020 |
Why?
|
| Wakefulness | 1 | 2010 | 75 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 50 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2010 | 94 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 62 | 0.020 |
Why?
|
| Propidium | 1 | 2009 | 26 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 71 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 58 | 0.020 |
Why?
|
| Lasers | 1 | 2009 | 61 | 0.020 |
Why?
|
| Brain Edema | 1 | 2009 | 50 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2009 | 66 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2009 | 235 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 219 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 171 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 658 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 4 | 0.020 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2006 | 13 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 946 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1663 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2006 | 152 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 567 | 0.020 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2003 | 4 | 0.010 |
Why?
|
| Rotenone | 1 | 2003 | 10 | 0.010 |
Why?
|
| Staurosporine | 1 | 2003 | 19 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2003 | 29 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1195 | 0.010 |
Why?
|
| Nucleus Accumbens | 1 | 2006 | 417 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 147 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 320 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 291 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1641 | 0.010 |
Why?
|